Why Fonterra may have dodged China’s ‘commercial casualty’ bullet
Jamie Ball Fri, 29 Aug 2014
Fonterra [NZX: FCG] needed to find a local partner if it intended to be relevant in the Chinese infant formula market and not end up a "commercial casualty," Lincoln University agribusiness professor Keith Woodford says.
“Fonterra has neither the capital nor expertise in consumer markets to
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).